United States · Series D startup
Funding summaryUpdated 26 Oct 2026
$143Mraised across 8 rounds since 2009, from 8 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $51M sold, first sale Dec 2014
From a historical funding recordSEC filing: $41M sold, first sale May 2014
No investor was named in the report.
Reported by sec.govSEC filing: $7.0M sold, first sale Aug 2013
No investor was named in the report.
Reported by businesswire.comSEC filing: $26M sold, first sale Apr 2011
No investor was named in the report.
Reported by sec.govSEC filing: $512K sold, first sale Oct 2011
Reported by businesswire.comSEC filing: $2.2M sold, first sale Apr 2011
No investor was named in the report.
Reported by sec.govSEC filing: $769K sold, first sale Mar 2010
No investor was named in the report.
From a historical funding recordSEC filing: $1.8M sold, first sale Dec 2008
From Aduro BioTech's own website and the SEC filings it signed: 14 on the team.
On the board, as filediFrank McCormickGerald David ChanRoss HaghighatStephanie O'BrienWilliam Greenman
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Morningside Group
OrbiMedMissing a round, or an investor who was in one? Tell us.
Aduro BioTech's investors include Morningside Group, OrbiMed, Johnson & Johnson Development Corporation (JJDC) and Janus Capital Group.
Aduro BioTech has raised $143M across 8 rounds since 2009.
Aduro BioTech's most recent round was a Series D of $51M in Jan 2015.
Aduro BioTech's largest round on record is $55M (Series C), in Jun 2014.
Aduro BioTech's first round on record, in Apr 2011, was backed by Morningside Group.
Aduro BioTech's latest named round is a Series D, in Jan 2015.
Aduro BioTech is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
